Test pumping is generally a high margin business due to the need for only a couple of workers - and revenue didn’t drop- so I can only assume it was costs for a) the trial work for injection testing and b) costs associated with commissioning the new rig. Potentially some small asset write offs too & increased depreciation. I’d expect it to return back to normal in h2.
Test pumping is generally a high margin business due to the need...
Add VYS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.010(3.03%) |
Mkt cap ! $138.9M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 31.8¢ | $305.7K | 920.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 57346 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 108843 | 2 |
View Market Depth
| Last trade - 13.34pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
32.0¢ |
Change
-0.010 ( 1.54 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 34.0¢ | 32.0¢ | 302900 | ||
| Last updated 13.35pm 15/05/2024 ? | |||||
| VYS (ASX) Chart |